DrugDashboards

Navitrux

fosaprepitant · FOSAPREPITANT DIMEGLUMINE 150 mg/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous · AVYXA Pharma, LLC

NDC 83831-0153-01 · 1 VIAL in 1 CARTON / 5 mL in 1 VIAL · NDA · View full market →

The short version

10 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$675.00
Reported to Texas DSHS · 2026 annual filing · Avyxa Pharma, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA220436
TE code
—
Approval date
Jun 24, 2026
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)Apr 8, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of fosaprepitant (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Novadoz Pharmaceuticals LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 3, 2026
Actavis Pharma, Inc.FOSAPREPITANT DIMEGLUMINE 150 mg/1Jul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.FOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
BluePoint LaboratoriesFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.,FOSAPREPITANT DIMEGLUMINE 150 mg/1Jul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.,FOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Aug 31, 2026
AVYXA Pharma, LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 31, 2026Aug 28, 2026
Avyxa Pharma, LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Jul 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Navitrux — NDC 83831-0153-01," retrieved September 3, 2026, https://drugdashboards.com/drug/83831015301.

Free to cite with attribution — see how the data is put together.